Human Papillomavirus and Oral Cancer

Dentistry Today

0 Shares

A study by Chaturvedi, et al, published in the Journal of Clinical Oncology, investigated the impact of human papillomavirus (HPV) on the epidemiology of oral squamous cell carcinomas (OSCCs) in the United States. The study assessed differences in patient characteristics, incidence, and survival between potentially HPV-related and HPV-unrelated OSCC sites. Data from 9 Surveillance, Epidemiology, and End Results program registries (1973 to 2004) were used to classify OSCCs by anatomic site as potentially HPV-related or HPV-unrelated. The join point regression and age-period-cohort models were used to assess incidence trends. Life-table analyses were used to compare 2-year overall survival for HPV-related and HPV-unrelated OSCCs. The study found that HPV-related OSCCs were diagnosed at younger ages than HPV-unrelated OSCCs. Incidence increased significantly for HPV-related OSCC from 1973 to 2004, particularly among white men and at younger ages. By contrast, incidence for HPV-unrelated OSCC was stable through 1982 and declined significantly during 1983 to 2004. When treated with radiation, improvements in 2-year survival across calendar periods were more pronounced for HPV-related OSCCs than HPV-unrelated OSCCs. During 1993 to 2004, for all stages treated with radiation, patients with HPV-related OSCCs had significantly higher survival rates than those with HPV-unrelated OSCCs. The study concluded that the proportion of OSCCs that are potentially HPV-related in-creased in the United States from 1973 to 2004, perhaps as a result of changing sexual behaviors. Recent improvements in survival with radiotherapy may be due in part to a shift in the etiology of OSCCs. 

(Source: Journal of Clinical Oncology. 2008; 26(4):612-619.)